Form 4: CONMED Corp Executive Hollie K. Foust Reports Stock Option Grant
SEC Form 4
Hollie K. Foust, General Counsel & Corp Sec of CONMED Corp, reports the acquisition of 30,738 stock options.
Summary
- On March 3, 2025, Hollie K. Foust, General Counsel & Corp Sec of CONMED Corp, reported a transaction.
- Foust acquired 30,738 options to purchase common stock at a price of $58.33.
- Following the transaction, Foust directly owns 30,738 derivative securities.
- The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't inherently convey positive or negative sentiment.
Positives
- The grant of stock options to a key executive aligns their interests with those of the shareholders.
Industry Context
This filing is a routine disclosure of stock option grants to company executives, which is a common practice in publicly traded companies to incentivize and retain key personnel.
Stakeholder Impact
- The stock option grant aligns the executive's interests with those of the shareholders, potentially incentivizing them to increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of earliest transaction: Stock options granted |
| 03/03/2025 | Transaction Date: Stock options granted |
| 03/05/2025 | Date of report filing |
| 03/03/2035 | Expiration Date: Stock options expire |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.